Arcutis Biotherapeutics, Inc. (ARQT)
26.46
+0.32
(+1.22%)
USD |
NASDAQ |
Sep 17, 16:00
26.45
-0.01
(-0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics 30-Day Average Daily Volume : 2.180M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 2.180M |
| September 16, 2026 | 2.066M |
| September 15, 2026 | 1.959M |
| September 14, 2026 | 1.896M |
| September 11, 2026 | 1.880M |
| September 10, 2026 | 1.854M |
| September 09, 2026 | 1.827M |
| September 08, 2026 | 1.786M |
| September 04, 2026 | 1.674M |
| September 03, 2026 | 1.646M |
| September 02, 2026 | 1.643M |
| September 01, 2026 | 1.605M |
| August 31, 2026 | 1.614M |
| August 28, 2026 | 1.605M |
| August 27, 2026 | 1.596M |
| August 26, 2026 | 1.581M |
| August 25, 2026 | 1.568M |
| August 24, 2026 | 1.554M |
| August 21, 2026 | 1.564M |
| August 20, 2026 | 1.545M |
| August 19, 2026 | 1.493M |
| August 18, 2026 | 1.519M |
| August 17, 2026 | 1.533M |
| August 14, 2026 | 1.519M |
| August 13, 2026 | 1.522M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.500M |
| August 11, 2026 | 1.506M |
| August 10, 2026 | 1.517M |
| August 07, 2026 | 1.571M |
| August 06, 2026 | 1.555M |
| August 05, 2026 | 1.515M |
| August 04, 2026 | 1.489M |
| August 03, 2026 | 1.476M |
| July 31, 2026 | 1.606M |
| July 30, 2026 | 1.608M |
| July 29, 2026 | 1.617M |
| July 28, 2026 | 1.645M |
| July 27, 2026 | 1.653M |
| July 24, 2026 | 1.705M |
| July 23, 2026 | 1.725M |
| July 22, 2026 | 1.750M |
| July 21, 2026 | 1.760M |
| July 20, 2026 | 1.755M |
| July 17, 2026 | 1.752M |
| July 16, 2026 | 1.745M |
| July 15, 2026 | 1.764M |
| July 14, 2026 | 1.767M |
| July 13, 2026 | 1.796M |
| July 10, 2026 | 1.780M |
| July 09, 2026 | 1.778M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.496M |
| Insmed, Inc. | 2.394M |
| Emergent BioSolutions, Inc. | 1.505M |
| Exelixis, Inc. | 2.284M |
| Vertex Pharmaceuticals, Inc. | 1.044M |